| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,406 |
3,961 |
$143K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,646 |
1,636 |
$32K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
635 |
617 |
$25K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
301 |
263 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
584 |
398 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,591 |
2,407 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
104 |
104 |
$6K |
| G9007 |
Coordinated care fee, scheduled team conference |
19 |
19 |
$2K |
| 87807 |
|
134 |
128 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
39 |
39 |
$2K |
| 92551 |
|
301 |
300 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
15 |
$961.60 |
| 0072A |
|
19 |
19 |
$716.44 |
| 81002 |
|
558 |
551 |
$639.39 |
| 0071A |
|
14 |
14 |
$516.44 |
| 94760 |
|
2,343 |
2,226 |
$335.57 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18 |
14 |
$172.80 |
| 90686 |
|
345 |
344 |
$137.61 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
12 |
$1.80 |
| 99080 |
|
280 |
263 |
$0.00 |
| 99499 |
|
84 |
81 |
$0.00 |
| 91307 |
|
41 |
40 |
$0.00 |